Back
NYLI US Large Cap R&D Leaders ETF Vs. Avidity Biosciences, Inc. Industry Stock Comparison
Buy
75
LRND
NYLI US Large Cap R&D Leaders ETF
Last Price:
$41.06
Seasonality Move:
3.96%
Buy
54
RNA
Avidity Biosciences, Inc.
Last Price:
$72.13
Seasonality Move:
29.53%
Buy
75
NYLI US Large Cap R&D Leaders ETF (LRND)
is a Buy
Is NYLI US Large Cap R&D Leaders ETF a Buy, Sell or Hold?
-
The current NYLI US Large Cap R&D Leaders ETF [LRND] share price is $40.81. The Score for LRND is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
LRND is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Avidity Biosciences, Inc. (RNA)
is a Buy
Is Avidity Biosciences, Inc. a Buy, Sell or Hold?
-
The current Avidity Biosciences, Inc. [RNA] share price is $72.14. The Score for RNA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
RNA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LRND Stock Price Chart
What is NYLI US Large Cap R&D Leaders ETF's stock price today?
-
The NYLI US Large Cap R&D Leaders ETF share price today is $40.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LRND is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences, Inc.'s stock price today?
-
The Avidity Biosciences, Inc. share price today is $72.14Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
LRND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 53.42 | Buy |
| Chaikin Money Flow: | -5503 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.91 - 41.13) | Buy |
| Bollinger Bands (100): | (38.27 - 40.85) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.81 | Buy |
| Relative Strength Index (14 RSI): | 73.62 | Buy |
| Chaikin Money Flow: | 329705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.08 - 72) | Buy |
| Bollinger Bands (100): | (43.34 - 68.74) | Buy |
LRND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.43 | Buy |
| 20-day SMA: | 40.75 | Buy |
| 50-day SMA: | 40.5 | Buy |
| 200-day SMA: | 36.65 | Buy |
| 8-day EMA: | 40.51 | Buy |
| 20-day EMA: | 40.57 | Buy |
| 50-day EMA: | 40.31 | Buy |
| 200-day EMA: | 37.67 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.04 | Buy |
| 20-day SMA: | 71.72 | Buy |
| 50-day SMA: | 66.96 | Buy |
| 200-day SMA: | 43.41 | Buy |
| 8-day EMA: | 51.62 | Buy |
| 20-day EMA: | 28.41 | Buy |
| 50-day EMA: | 13.08 | Buy |
| 200-day EMA: | 3.52 | Buy |
NYLI US Large Cap R&D Leaders ETF Earnings Growth & LRND Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences, Inc. Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.63 per share, and a decrease next year of $0.40 per share.
NYLI US Large Cap R&D Leaders ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||